Novel Cu(I)-catalyzed one-pot multicomponent synthesis of the antiepileptic drug rufinamide

Novel Cu(I)-catalyzed one-pot multicomponent synthesis of the antiepileptic drug rufinamide NH [Cu(phen)(PPh ) ]NO Br 2 3 2 3 NH NaN , H O, 60 °C, 2 h 3 2 antiepileptic drug Rufinamide (95%) Keywords Rufinamide  2,6-Difluoro benzyl bromide  Green Media  Antiepileptic drug  1,3-Dipolar cycloaddition Electronic supplementary material The online version of this article (doi:10.1007/s11164-017-2906-7) contains supplementary material, which is available to authorized users. & Kaushik Chanda chandakaushik1@gmail.com Department of Chemistry, School of Advanced Sciences, VIT University, Vellore 632014, India 123 4712 D. R. Meena et al. Introduction The disease, epilepsy caused by the chronic neurological disorder of the brain affecting almost people of all ages [1]. According to the World Health Organization (WHO) estimates, out of the 50 million people suffering from different forms of epilepsy worldwide, 80% people is residing in developing countries [2, 3]. The majority of epileptic seizures are controlled by the use of anticonvulsants drugs [4, 5] which are often associated with related side-effects such as blurry vision, fatigue, sleepiness, and stomach upset [6]. In view of the side effects, it is always imperative to develop the new anti epileptic drug (AED). An important example of 1,2,3-triazole ring containing antiepileptic drug is rufinamide developed by Novartis and manufactured by Eisai http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Research on Chemical Intermediates Springer Journals

Novel Cu(I)-catalyzed one-pot multicomponent synthesis of the antiepileptic drug rufinamide

Loading next page...
 
/lp/springer_journal/novel-cu-i-catalyzed-one-pot-multicomponent-synthesis-of-the-y3OnyCH7w2
Publisher
Springer Netherlands
Copyright
Copyright © 2017 by Springer Science+Business Media Dordrecht
Subject
Chemistry; Catalysis; Physical Chemistry; Inorganic Chemistry
ISSN
0922-6168
eISSN
1568-5675
D.O.I.
10.1007/s11164-017-2906-7
Publisher site
See Article on Publisher Site

Abstract

NH [Cu(phen)(PPh ) ]NO Br 2 3 2 3 NH NaN , H O, 60 °C, 2 h 3 2 antiepileptic drug Rufinamide (95%) Keywords Rufinamide  2,6-Difluoro benzyl bromide  Green Media  Antiepileptic drug  1,3-Dipolar cycloaddition Electronic supplementary material The online version of this article (doi:10.1007/s11164-017-2906-7) contains supplementary material, which is available to authorized users. & Kaushik Chanda chandakaushik1@gmail.com Department of Chemistry, School of Advanced Sciences, VIT University, Vellore 632014, India 123 4712 D. R. Meena et al. Introduction The disease, epilepsy caused by the chronic neurological disorder of the brain affecting almost people of all ages [1]. According to the World Health Organization (WHO) estimates, out of the 50 million people suffering from different forms of epilepsy worldwide, 80% people is residing in developing countries [2, 3]. The majority of epileptic seizures are controlled by the use of anticonvulsants drugs [4, 5] which are often associated with related side-effects such as blurry vision, fatigue, sleepiness, and stomach upset [6]. In view of the side effects, it is always imperative to develop the new anti epileptic drug (AED). An important example of 1,2,3-triazole ring containing antiepileptic drug is rufinamide developed by Novartis and manufactured by Eisai

Journal

Research on Chemical IntermediatesSpringer Journals

Published: Feb 25, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from Google Scholar, PubMed
Create lists to organize your research
Export lists, citations
Access to DeepDyve database
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off